|
Variables
|
Startification
|
Over all
|
BDca
|
GBca
|
|---|
|
Spieces of cancer
| |
42
|
27
|
15
|
|
Sex
|
(male/female)
|
(24/18)
|
(17/10)
|
(7/8)
|
|
Age
| |
66.5 ± 7.5
|
64.8 ± 8.2
|
69.5 ± 4.7
|
|
ECOG PS
|
(0/1/2)
|
(36/4/2)
|
(22/4/1)
|
(14/0/1)
|
|
Disease Status
|
(unresectable/postoperative recurrence)
|
(26/16)
|
(15/12)
|
(11/4)
|
|
Disease extension
|
locally advanced (primary)
|
26
|
15
|
11
|
| |
local recurrence
|
7
|
7
|
0
|
| |
liver metastasis
|
9
|
4
|
5
|
| |
lung metastasis
|
4
|
3
|
1
|
| |
lymphnode metastasis
|
11
|
4
|
7
|
| |
miscellaneous metastasis
|
5
|
5
|
0
|
|
Tumor marker
|
carcinoembryonic antigen (CEA)
|
16.7 ± 60.7
|
6.4 ± 17.2
|
36.7 ± 100.5
|
| |
CA19-9
|
3035.5 ± 9507.6
|
4495.3 ± 11688.8
|
407.9 ± 587.2
|
|
Previous chemotherapy
|
(yes/no)
|
(4/38)
|
(3/24)
|
(1/14)
|
- Abbreveations
- BDca: bile duct carcinoma, GBca: Gallbladder carcinoma, ECOG PS: Eastern Cooperative Oncology Group performance status
